Interviews With The Candidates For WIPO Director General 12/02/2014 by William New, Intellectual Property Watch 4 Comments Member states of the UN World Intellectual Property Organization, the global body for international IP policy issues, will vote on 6 March for the next WIPO director general for six years. Intellectual Property Watch asked the candidates four key questions. Here are their responses.
Alert: Pharma IPR 2014 Conference In Mumbai, 26-28 February 10/02/2014 by Intellectual Property Watch Leave a Comment Dear Subscribers, CPhI’s 3rd Annual Pharma IPR 2014 conference to take place from 26-28 February, 2014 in Mumbai, India will have techno-legal experts from over 10+ regions speaking on the recent case studies on global Pharma and Biopharma patent laws. Among them, Jeffery Alan Hovden, Partner, Robins, Kaplan, Miller & Ciresi LLP from US will be speaking on critical developments in US pharma patent law in the year 2013 which have affected pharma and biopharma industry. He will also share best strategies on how Indian generic-drug and biologics enterprises need to go forward with their US-related projects. Some of the critical concerns he is planning to address include: Which pharmaceutical and diagnostic compounds and processes can even obtain a US patent? Whether the new, cheap and fast patent-challenge procedures are right for Indian companies in the life-sciences area? How to avoid paying the attorney fees for the other side in US litigation and indeed, how an Indian company might turn the tables and have the other side pay the company’s attorney fees? You can view his insights on “US Patent Law in 2013: Winds of Change” by clicking here. To optimise interactions with the audience, he and other global techno-legal experts would also be available in query handling sessions as well as one-on-one meetings, to discuss your concerns related to the US patent system. Click here to go through the detailed programme agenda. You can read more about the conference speakers here. To be a part of this exclusive event, please contact the organisers at +91 (22) 6172 7001 / conferences-india@ubm.com, or register online and take advantage of the special offers for you as you are our subscribers. P.S. You may find one of his earlier presentations on “From Small to Big: Some useful points in the coming shift from customary drugs to biologics” interesting – View the presentation here
WIPO Genetic Resources Text Compiles Differences, Heads To General Assembly 10/02/2014 by Catherine Saez, Intellectual Property Watch 3 Comments Despite spending a week in mostly closed, informal discussions, the World Intellectual Property Organization committee working on the protection of genetic resources, got little closer to breaching the opposing viewpoints. Members managed to produce a draft text – with signs of steps toward a middle ground – that they say can serve as a basis for further discussion on the development of an international instrument preventing wrongful patents.
Small-Scale Farmers’ Innovation Overlooked In WIPO Negotiations, Panellists Say 07/02/2014 by Maëli Astruc for Intellectual Property Watch 1 Comment A side event hosted by the Quaker United Nations Office (QUNO) this week called on negotiators at the World Intellectual Property Organization to include innovation by small-scale farmers and asked for complementarity of several international instruments dealing with this issue.
Indigenous Panel At WIPO Asks For International Instrument Compliant With Recognised Rights 06/02/2014 by Maëli Astruc for Intellectual Property Watch Leave a Comment A panel addressing negotiators this week at the World Intellectual Property Organization asserted the property rights of Indigenous Peoples and Local Communities over traditional knowledge and genetic resources and called on delegates to draft an international instrument compliant with their internationally recognised rights.
New WIPO Text On Genetic Resources Misappropriation; Disclosure Still Uncertain 06/02/2014 by Catherine Saez, Intellectual Property Watch 4 Comments World Intellectual Property Organization member countries are working to get past their differences this week toward agreement on a way to protect genetic resources from biopiracy. A new document shows focus on misappropriation as a policy objective, and that a bridge still needs to be found on the issue of mandatory disclosure of origin in patent applications.
Amid Proposals, Ambassadors Fail To Unlock WIPO Talks On TK, GRs 04/02/2014 by Catherine Saez, Intellectual Property Watch 1 Comment The World Intellectual Property Organization committee working on ways to protect genetic resources and traditional knowledge opened a weeklong meeting yesterday by gathering country ambassadors to try to inject momentum into discussions. But after the session, it appeared that many delegations had restated known positions. Everybody seemed to agree on broad goals, but not on the way to reach them.
US Highest, India Lowest On US Chamber International IP Index 31/01/2014 by Julia Fraser for Intellectual Property Watch Leave a Comment The United States Chamber of Commerce Global Intellectual Property Center this week released a report ranking 25 countries on their IP environment.
New Study Makes Case for Innovative Medicines 31/01/2014 by Julia Fraser for Intellectual Property Watch Leave a Comment A new pharmaceutical industry-backed study draws attention to the value of innovative medicines in reducing healthcare costs and to the wider society that goes beyond clinical and personal values. However, in middle income countries, national prioritisation and improvements in healthcare infrastructure are needed to maximise the value of medicinal innovation, the study found.
At WIPO, Global Experts Share Experiences On Open Collaboration 29/01/2014 by Julia Fraser for Intellectual Property Watch 1 Comment The recent World Intellectual Property Organization Conference on Open Innovation: Collaborative Projects and the Future of Knowledge showed the potential of open collaborative innovation in confronting some of today’s greatest challenges. This model of innovation is used in industries ranging from health research and solutions to climate change to film production and museum design.